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ABSTRACT
High fiber/plant-based diet and fasting and timed feeding protocols under a high-fat
diet change the gut microbiota, the histological structure, and the immune parameters of the
intestine. The purpose of this study was to assess the influence of different dietary
interventions, including a high-fiber/plant-based or a high-fat diet, and several time-restricted
feeding protocols, on the intestinal crypt and villus morphology, the number of intestinal
goblet cells (GC), and the changes in inflammatory parameters. Healthy C57BL/6 male mice
were fed a high fat (HF) diet for 6 weeks, and then randomly divided to follow 1)
continual-ad libitum high-fat diet (HFD), 2) a chow diet (SW-C), 3) purified high-fiber diet
(Daniel Fast, DF), 4) calorie restricted HF diet , 5) a HF diet with time-restricted feeding
(TRF) or 6) a HF diet with alternate-day fasting (ADF). The histological change of villi and
crypt was assessed by hematoxylin & eosin, and Periodic Acid-Schiff (PAS)-Alcian Blue
(AB) was used to assess the change in GCs number. We also examined changes to the
immune parameters in intestinal tissues by RT-PCR. Morphologically, HF resulted in a
significant reduction in crypt depth of the small intestine and colon, while DF had a slightly
longer crypt depth. DF also significantly increased the number of GCs in the crypt region of
the colon. The number of GCs was also increased in colon-villi of DF group.The expression
level of RORγt was induced in all high fat diet groups while the DF group had a lower level
of RORγt expression. DF also had a high level of Foxp3+ expression. These data suggest that
the compositions of diet is what have the significant effect on intestinal architecture and
immunity rather than fasting and different timed feeding protocols.
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BACKGROUND
Introduction
The contribution of the gut microbiome in developing several chronic and metabolic
diseases has become an inevitable fact. Various studies have investigated the association
between the asymmetry of intestinal microbiota (dysbiosis) and its role in developing
numerous diseases such as inflammatory bowel disease (IBS) that includes ulcerative colitis
(UC) and Crohn's disease (CD), irritable bowel syndrome, obesity, diabetes mellitus,
cardiovascular disease, atherosclerosis and cancer (1-4). Multiple factors can modify and
influence the abundance and the diversity of the communities of intestinal microbiota. For
instance, the intestinal inflammation and a reduction of antimicrobial peptides during the
burn injuries showed a shift in the community structure of the microbiome (5). Excessive
doses of antibiotics and exposure to the toxic chemical substances are other causes of
collapsing and losing the intestinal microbiota equilibrium (6). However, diet is considered a
critical determinant that plays a significant role in altering the microbiome composition.
Shifting between diets as animal-or-plant-based diets can dramatically change the abundance
and the diversity of the bacterial communities within 24 hours and reverse them to the
baseline within 48 hours (7). For this reason, remodeling the intestinal microbial composition
through the diet may have an effective therapeutic modality to improve intestinal health. We
have previously demonstrated that specific purified diets can alter the gut microbiome. Thus,
the aim of this study is to evaluate the effect of diet/microbiome changes on the
morphological structure of the small and large intestine, and intestinal immune parameters.
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The Correlation Between Diet and Microbiome
Introduction to Gut Microbiota and Diets
The human gastrointestinal tract (GIT) relatively includes 1014 microbes that interact
with the host's cells and participate in manufacturing thousands of metabolites such as
short-chain fatty acids (SCFAs), trimethylamine, indolepropionic acid, and gases. Most of
those microbes are bacteria, but other microorganisms such as viruses, fungi, archaea, and
protozoa are also present. (3, 4). In addition to the tremendous number of microbes, the genes
encoded by the bacteria that inhabit the human GIT is 100 times more than present in their
host genome (8). Firm evidence exists that diets and food components can influence the
abundance and the diversity of these microbes, where the consumption of high fat- and-sugar
diets is more linked with dysbiosis (9),while the high fiber diet is associated with a healthier,
functional, and richer intestinal microbiota (10). Probiotics (in-foods or as supplements) have
displayed some beneficial function in regulating intestinal health and increase bacterial
abundance as well (4, 11). Other dietary components that interact with gut microbiota are
polyphenols. Foods rich in polyphenols such as seeds, vegetables, fruits, tea, and wine have
been linked to increasing the abundance of particular species of microbiota and decreasing
others (4, 12). Similarly, fasting protocols as the intermittent fast regimen may play a role in
shaping the gut microbiota composition and increasing fermentation products such as acetate
and lactate (13). This relationship between diet and gut microbiota will be discussed in depth
in this literature based on different diet regimens; high-fat Western-style diet, plant-based
diet, time-restricted feeding (intermittent fasting), pre/probiotics- containing foods, and other
regimens like FODMAPs-gluten-free, and Mediterranean diets.
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High-Fat Western-Style Diet
A high-fat Western-style diet is characterized by high consumption of processed
foods that contain refined grains, sugar, red meat, saturated fat, and is reduced in fiber. This
dietary pattern results in a gut microbiome with a reduced abundance and diversity, and has
been associated with several health issues (14, 15). For instance, an experimental murine
study, where both lean wild-type and RELMβ KO (weight-gain resistant) mice a high-fat
diet (40% to 80% of total calorie intake) for three months, showed a reduction in
Bacteroidetes with a concomitant increase in Firmicutes and Proteobacteria in all mice.
Hence, these outcomes that were observed even in weight-gain resistant mice (RELMβ KO
mice) signify the direct impact of a high fat diet on the microbiota (16). A high fat diet with
or without ethanol influenced the fecal microbiome community, where sugar and butter
(HSB) diet with ethanol for eight weeks had a direct effect on the abundance of Firmicutes
and Actinobacteria phylum as well as Clostridiaceae and Coriobacteriaceae family. The
high sugar and butter (HSB) diet by itself affected the abundance of Bacteroidales family and
changed the Firmicutes/Bacteroidetes ratio (17). In the context of studying the dietary effect
of fat and sugar, 27-male rats were divided randomly into three dietary groups 1) standard
diet (STD), 2) high-fat (HF; 45% of total calorie) 3) high-sucrose (HS; standard diet with
35% sucrose) with over 24-weeks period of intervention. The high-fat diet resulted in a
reduction in the Bacteroidetes/Firmicutes ratio, while the high-sucrose diet caused an
increase in this ratio. The Enterobacteriales and E. coli communities were also increased in
rats given excessive fructose (18). In addition to red meat, the western-style diet is also high
in saturated fat. Thus, the different sources of dietary protein in the western diet can also
influence microbial diversity. A recent study demonstrated the effect of high-fat soy protein
(HFS) vs. high-fat beef protein (HFB) on the diversity of the bacterial community in mice
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fed a low-fat (12% of total calorie) or a high-fat diet (60% of total calorie). The high-fat beef
protein group vs. high-fat soy protein significantly reduced the abundance of Akkermansia
Muciniphila and butyrate-producing bacteria, including Anaerotruncus, Butyricicoccus, and
Lactobacillus even though the Firmicutes to Bacteroidetes ratio was increased in all protein
groups consuming a high-fat diet (19). However, the consumption of salmon as a source of
protein and fish oil (mono and polyunsaturated fats) displayed a limited effect on the fecal
microbiota of 123 subjects (20). Various types of fats have a different impact on intestinal
microflora. For example, a murine study demonstrated a higher abundance of Bacteroides
and Bilophila in lard fed vs. fish oil fed mice. In addition, other beneficial microbial species
were increased in fish oil -fed mice, including Bifidobacterium, Adlercreutzia
(Actinobacteria), Lactobacillus, and Streptococcus (lactic-acid producer bacteria), and
Akkermansia Muciniphila (Verrucomicrobia) (21).
In conclusion, most of the studies prove that High-fat Western-style diet has an
influence on gut-microbiota, especially the abundance and the diversity of Firmicutes to
Bacteroidetes communities. This increase in Firmicutes to Bacteroidetes ratio has strongly
linked to saturated fat more than mono and polyunsaturated fat, and it might be associated
with multiple metabolic disorders, including obesity, diabetes, and cardiovascular diseases.
Thus, these findings may suggest that various dietary patterns like a plant-based diet or
Mediterranean diet might have a favorable influence on the intestinal microbiota
bioactivities.
Plant-Based Diet
Although the higher intake of total processed foods and refined grains as in
Western-style diets are strongly associated with the depletion in microbiome diversity, a
plant-based diet rich in vegetables, fruits, legumes, and whole grains are associated with
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increased diversity in the gut microbiome. The main components of a plant-based diet that
impacts gut microbiota include fibers and polyphenols. These plant components promote the
abundance of beneficial bacteria such as Bifidobacterium and Lactobacillus that have
anti-pathogenic and anti-inflammatory effects (22). In a randomized controlled trial (RCT)
that investigated the impact of fruits and vegetable consumption on gut microbiota showed
an inhibitory effect on pathogenic clostridia growth, while the diversity of Clostridium
leptum and Ruminococcus bromii and flavefaciens were significantly increased (23). Both
Clostridium leptum and Ruminococcus are reduced in inflammatory bowel disease (IBD) (24,
25). Additionally, a recent experimental study that examined the function of dietary fiber on
polyposis mice proved the corrective role of dietary fiber on gut microbiome composition.
Mice were fed either a standard rodent chow diet with or without increased fiber for twelve
weeks. The results demonstrated that the high-fiber diet significantly increased the level of
short-chain fatty acid (SCFA)-producing bacteria (Bifidobacterium, Lachnospiraceae, and
Anaerostipes) and colonic SCFA concentration and that this increase correlates improvement
in polyposis (26). The non-digestible fibers of Granny Smith apples are also able to alter the
microbiota in obese mice; with the consumption of this fibers, the abundance of Firmicutes,
Bacteroidetes, Enterococcus, Enterobacteriaceae, Escherichia coli, and Bifidobacterium in
obese mice and production of butyric acid were more similar to lean control mice (27).
Consistent with animal studies, a single-center, double-blind, placebo-controlled trial with 53
adults demonstrated that pea fiber (PF) increased the SCFA producer Lachnospira and fecal
SCFAs compared to control (28). A systematic review study also demonstrated that the
mucin degrading bacteria, Akkermansia muciniphila, was increased with the consumption of
pomegranate extract, resveratrol, polydextrose, yeast fermentate, sodium butyrate, and inulin.
In fact, the abundance of A. muciniphila is reduced with low oligosaccharides, disaccharides,
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monosaccharides, and polyols diet. Likewise, Faecalibacterium prausnitzii is also increased
with the consumption of various types of fibers, including fructo-oligosaccharides,
inulin-type fructans, and raffinose (29). A plant-based diet is also rich in polyphenols, and it
has also been shown to modulate gut microflora. Curcumin, a bioactive component in
turmeric, has been found to alter the gut microbiota of C57BL/6 mice. The abundance of
Bacteroidaceae and Rikenellaceae was significantly higher in the curcumin group than the
control group (from 3.21% to 1.15%, and from 4.73% to 7.96%; respectively). Additionally,
Prevotellaceae has decreased the abundance relative to the control group (from 15.48% to
6.16%) (30). Quercetin and resveratrol are other plant polyphenols found in fruits and
vegetables and have a favorable impact on modulating microbiota. In a study using Wistar
rats fed normal-diet (ND) or high-fat diet (HFD), with or without quercetin and resveratrol
(CQR) demonstrated the decreased ratio of Firmicutes to Bacteroidetes. Moreover, it
inhibited several species that potentially related to diet-induced obesity such as
Desulfovibrionaceae, Acidaminococcaceae, Coriobacteriaceae, Bilophila, Lachnospiraceae,
and its genus Lachnoclostridium. At the same time, compared with HFD, Akkermansia,
Ruminococcaceae, Christensenellaceae, and Bacteroidales that are related to ameliorating
the HFD-induced obesity, were increased in the CQR group (31). Phenols in green tea,
oolong tea, and black tea also altered the intestinal microflora of high-fat-diet-induced obese
C57BL/6J mice where Alistipes, Rikenella, Lachnospiraceae, Akkermansia, Bacteroides,
Allobaculum, Parabacteroides were increased substantially in diversity (32).
In summary, most of the studies demonstrated the influence of a plant-based diet in
increasing the richnesses of gut microflora. The high diversity has been associated with
desirable impact and general health where Bifidobacterium and Lactobacillus showed
anti-pathogenic and anti-inflammatory effects. The reduction in Firmicutes to Bacteroidetes
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ratio has also improved with a plant-based diet compared with HFD (22, 31). Colonic SCFAs
concentration was also increased with a plant-based diet, and this demonstrates the favorable
influence of the plant-based diet on intestinal health and microbiotas (26).
Time-Restricted Eating (Intermittent Fasting)
The time-restricted eating pattern demonstrates a favorable influence on human
health and metabolism, including reducing adipose hypertrophy, preventing whitening of
brown adipose cells, improving heart health, preserving muscle mass and fitness, reversing
liver steatosis, and sustaining gut integrity (33). However, time-restricted feeding (TRF) and
gut-microbiotas relationships require more investigation. Intermittent fasting (IF) regimen
increased the level of lactobacillus, Oscillospira, Ruminococcus, and Firmicutes while
Akkermansia muciniphila, Bacteroides, and Bifidobacterium reduced during the feeding.
(34). Another study demonstrated that mucin degrading bacteria, Akkermansia muciniphila,
was increased during fasting (35). This demonstrates that fasting may increase A.
muciniphila while feeding may have a contrary influence. Similar results were found in
another fasting program where A. muciniphila, Faecalibacterium prausnitzii, and
Bifidobacteria were increased in abundance (36). Eventually, this relationship needs to be
confirmed by conducting further randomized controlled trials (RCT) to cover the shortage
and demonstrate it more precisely with more concentration on the variations in the timing of
fasting and feeding.
Probiotics
Probiotics have been defined by the Food and Agriculture Organization of the United
Nations and the World Health Organization (FAO/WHO) as " live microorganisms which,
when administered in adequate amounts, confer a health beneﬁt on the host" (37). Probiotics
could be bacterial genera, including Lactobacillus and Bifidobacterium, Enterococcus,
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Streptococcus, and Escherichia, or might be fungus as Saccharomyces boulardii (38). The
definition involves both fermented foods (having living microbes), or commensal microbes
as supplements (37). Probiotics intake was hypothesized to modulate the structure of gut
microbiota. A randomized placebo-controlled trial found administering probiotics, including
Lactobacilli, Bifidobacteria, and Streptococcus with or without omega-3-fatty acid,
significantly increased their concentration compared to control-individuals as well as the
abundance of E. coli and Bacteroides (39). In a recent randomized clinical trial, multispecies
probiotics boosted the Lactobacillus strains (salivarius, brevis, and lactis) in cirrhosis
patients. The abundance of different species, including Faecalibacterium prausnitzii,
Syntrophococcus sucromutans, Bacteroides vulgatus, Alistipes shahii, and Prevotella were
also increased (40). Individuals who consumed two servings of probiotic fermented milk
(PFM) every day for three weeks, showed a significant increase in abundance of Bacteroides
species with a concomitant decrease in Firmicutes; during the PFM ingestion period. This
correlation was reversed after discontinuing PFM ingestion, which suggests that fermented
foods can modify the abundance of gut-microbiota, but not colonization (41). Another study
also demonstrates the impact of probiotic fermented milk (PFM) and yogurt with or without
Bifidobacterium and Lactobacillus. PFM increased the Bifidobacteria level in general, where
B. longum increased with PFM + Lactobacillus intake while B. animalis increased with
consumption of PFM + Bifidobacterium. Streptococcus thermophilus was promoted with
yogurt consumption (42).
As we have seen, probiotics in either fermented foods or supplements could modulate
intestinal microbiota. In fact, specific probiotic species can increase their own concentration,
which might be beneficial to target a particular species and its benefits, as we have seen with
cirrhosis patients (39, 40).
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Various Types of Diets
Low FODMAPs Diet
FODMAP is an abbreviation for Fermentable Oligosaccharides, Disaccharides,
Monosaccharides, And Polyols, which are non-digestible carbohydrates (prebiotics) that can
be fermented by gut microbiota. Low FODMAP diet can relieve the symptoms of IBS
(bloating, diarrhea, or abdominal pain) by reducing the fermentation products like hydrogen
or methane gas, but no influence has been found for low-FODMAP diet on intestinal
inflammation in IBS patients (43). The reduction in fibers (prebiotics) in a low FODMAP
diet may affect the diversity of intestinal-microbiotas. In a single-blinded, randomized,
cross-over trial, a low FODMAP diet showed a reduction in the total abundance of gut
microbiota in compared to the typical-control Australian diet that increased the abundance of
butyrate-producing Clostridium cluster XIVa and Akkermansia muciniphila and reduced
Ruminococcus torques (44). In another similar study, low and habitual FODMAPs diets did
not alter the total abundance of fecal microbiota compared to the Australian-control diet that
increases A. muciniphila, and butyrate-producing Clostridium cluster XIVa with a
concomitant decreased in Ruminococcus torques (45). In a parallel randomized controlled
trial, a low FODMAP diet was associated with a depletion in Bifidobacterium in 37 healthy
adults, while oligofructose and maltodextrin supplement induced the abundance of
Lachnospiraceae and Ruminococcaceae respectively (46).
In conclusion, a negative correlation was found between gut microbiota and a low
FODMAPs diet. This relationship seems due to the low amount of prebiotics, where
oligofructose and maltodextrin induce the abundance of some species (46). Also, this conflict
may limit the therapeutic role of microbiota in ameliorating IBS.
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Mediterranean Diet
Mediterranean-style diet is distinguished by limited consumption of red meats and
saturated fats and moderate intake of fish, poultry, fruits, and vegetables that are rich in
antioxidants and polyphenols (4, 47). Thus, the Mediterranean diet may have an influence on
gut microbiota. In 2016, a study showed that high adherence to a Mediterranean-style diet
increases the fecal short-chain fatty acids significantly. Prevotella bacteria and some
fiber-degrading Firmicutes were also increased (48). Similarly, long-term adherence to the
Mediterranean-style diet revealed a higher bifidobacteria: E. coli ratio, Candida albicans
prevalence, and lower Escherichia coli count. The total bacteria and SCFAs were positively
associated with adherence to a Mediterranean-style diet, while cultivable E. coli was
negatively correlated (49).
Mediterranean-style diet seems to have a desirable influence on gut-microbiotas,
particularly SCFAs-producing bacteria, where fecal short-chain fatty acids were increased in
both studies. High and long-term adherence seems to be required, which may make it more
challenging. However, still, there is a shortage, and more experimental studies are needed.
Short-Chain Fatty Acids (SCFAs) and Microbiome
The non-digested carbohydrates like (cellulose, xylans, resistant starch, and inulin)
and prebiotics such as (oligosaccharides, galactooligosaccharides, fructooligosaccharides) are
hydrolyzed and fermented by gut microbiota to generate mainly short-chain fatty acids
(SCFAs) products, including acetate, propionate, and butyrate (50). Anaerobic bacteria such
as Firmicutes and Bacteroidetes show the ability to hydrolyze non-digestible
complex-carbohydrates while other species, including Lactobacillus and Bifidobacterium, are
more specialized in oligosaccharide, galactooligosaccharides, fructooligosaccharides (51).
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SCFAs metabolites (acetate, propionate, and butyrate) demonstrate several beneficial
functions in mammalian metabolism by activating G-coupled-protein receptors that induce
cell-signaling pathways and serving as energy substrates for the intestinal epithelial cells of
host (52). Numerous G-protein coupled receptors (free fatty acid receptors) have been
identified, including GPR41, GPR43, olfactory receptor 78, and GPR109A (50, 53). The two
G-protein coupled receptors (GPR41 and GPR109A) that are found on the intestinal
epithelial cells, immune cells, and adipocytes, are activated by SCFAs metabolites (sever as
endogenous agonists) to transduce signal for several physiological functions (53). GPR41
activation leads to an increase in energy expenditure, release of leptin by elevating the gene
expression and decrease the consumption of the foods (54). Stimulating GPR109A by
butyrate or niacin (GPR109A is also a receptor for vitamin B3, niacin) showed
anti-inflammatory properties and suppressed colitis and colon cancer (55). GPR109A also
inhibits lipolysis in adipose tissue and lowering blood triglyceride and low-density
lipoprotein (43). Therefore, butyrate might have the same properties as niacin as a
lipid-lowering agent. Acetate and propionate can also activate GPR43 receptor that induces
the chemotaxis of neutrophils and production of both peptide YY (PYY) and glucagon-like
peptide 1 (GLP-1). PYY could suppress intestinal transit and appetite, while GLP-1 is
anorexigenic and can stimulate insulin secretion. GPR43 also has an anti-lipolysis influence
in mature fat tissues (56). Lack of butyrate during the dysbiosis can suppress the
beta-oxidation in mitochondrial colonocytes, resulting in moving the oxygen from the blood
to the GI lumen via the free diffusion. Existent oxygen encourages pathogenic facultative
anaerobic bacteria to grow at the expense of obligate anaerobic bacteria that produce SCFAs
(57). Butyrate also activates a nuclear receptor called peroxisome proliferator-activated
receptor gamma (PPAR-gamma) that plays a role in activating the responsible gene of
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glucose and lipid metabolism. The lack of butyrate signaling will result in increased nitrate
levels that could be used in cell respiration by facultative anaerobic bacteria that lead to
degrading carbohydrates into carbon dioxide instead of being used in fermentation (58).
To put it together, different SCFAs receptors, including GPR41, GPR43, olfactory
receptor 78, and GPR109A on intestinal epithelial cells, adipocytes, and immune cells,
reflect the importance of gut-microbiota metabolites (acetate, propionate, and butyrate).
Different SCFAs activate different G-protein coupled receptors that result in several
physiological functions, including anti-inflammatory properties, regulate energy, producing
hormones, and engaging in lipid and carbohydrate metabolisms.
The Interaction Between Gut Microbiota and Intestinal Mucosal Immune System
Recognizing the difference between commensal and pathogenic bacteria is regulated
by the response of the immune system that involves several strategies, including the mucus
layer, secreting antimicrobial peptide (AMPs), soluble cytokines, IgA, or activating innate
lymphoid cells (ILCs) (59). The mucus layer on the top of intestinal epithelial cells is
considered the first line of defense, which segregates the microbiota from the intestinal
epithelium, while Paneth cells in crypts of epithelium secrete antimicrobial peptide (AMPs),
in cross-linking with the mucus layer (60). Both the mucus layer and AMPs collaborate to
prevent the invasion of bacteria. The AMPs have antimicrobial functions, including release
alpha-defensins, RegIII, lysozymes, and angiogenins. The antimicrobial influence of AMPs
can neutralize microorganisms (gram-negative/positive bacteria), reduce the pathogenic
microbes' activity, and protect against irregular immune response (60-62). The expression of
RegIIIγ, cryptdin, and human β-defensin 2 increase in the presence of bacteria and their
antigen while the absence of RegIIIγ elevates the bacterial colonization and activates the
adaptive immune system (63). The epithelium and lymphoid Pattern Recognition Receptors
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(PRRs), including Toll-like Receptors (TLRs) and Nucleotide-binding Oligomerization
Domain-containing Protein 2 (NOD2) is involved in recognizing the various types of
Microbe-associated Molecular Patterns (MAMPs) antigens such as lipopolysaccharides,
flagellin, muramic acid, and capsular polysaccharides (61, 64). This process triggers a
nuclear factor called kappa-light-chain-enhancer of activated B cells (NF-kB) to increase the
transcription genes of cytokine and chemokines production (65). Releasing cytokines such as
IL-33, TGF-β, TSLP, BAFF, and APRIL through PRRs-MAMPs interaction, enriched
CD103+ dendritic cells (DCs) and induce T-regulatory cells development, and IL-10 and
TGF-β production. These cytokines are responsible for a tolerogenic immune response to the
commensal-microbiota. While releasing different types of epithelium cytokines, including
IL-1 and IL-6 in response to pathogenic microbes, triggers a pro-inflammatory response (66).
The deficiency in the specific PRR, NLRP6 was associated with alteration in the immune
response by reducing IL-18 levels, and fecal microbiota (67).
Intestinal microbiota also has the ability to induce the differentiation of T cells (naive
CD8+ T cells toward CD4+ T cells) into T-helper cells (Th), including Th1, Th2, and Th17,
and CD4+Foxp3+ regulatory T cells (iTregs) (68, 69). Th17 cells secrete several cytokines
like IL-17A, IL-17F, IL-21, and IL-22 that have a significant influence in inducing intestinal
inflammation (70). Th17 and CD4 Foxp3 iTregs cytokines are working opposite each other,
where IL-17 and IL-22 differentiate during the time of IL-10 inhibition (71). In an
experimental mice study, Purified Polysaccharide A (PSA) from commensal bacteria
(Bacteroides fragilis) suppressed the pro-inflammatory interleukin-17 production and
activated the interleukin-10-producing CD4+ T cells (72). In fact, polysaccharide A of B.
fragilis showed an immunomodulatory effect by regulating the conversion of CD4+ T cells
into Foxp3+ Treg cells that secrete anti-inflammatory IL-10 (73). Clostridia strains (clusters
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IV, XIVa, and XVIII) colonization has also increased Transforming Growth Factor-Beta 1
(TGF-β1) production that promotes the differentiation of Foxp3+ Tregs and IL-10 excretion
(74). IgA also has a crucial role in the mucosal immune system. The microfold cells (M
cells) in Peyer's patches transfer various antigens by antigen-presenting cells such as
Dendritic cells (DCs) to activate naive T cells for appropriate immune response. Thus, the
commensal bacterial antigens function in IgA production and intestinal immune homeostasis
(75). At the same time, existing cytokines like IL-10, TGF-β, IL-4, IL-5, and IL-6 stimulate
IgA production as well (76).
The Influence of Microbiome on Intestinal Morphological Structure
The influence of diets on the intestinal microbiota may impact the histological
structure of the intestine, where diets, microbiota, SCFAs, immune cells, and epithelium are
interacting with each other. A recent mice study found that a high-fat diet (FHD) induced the
abundance of inflammation-producing bacteria (Desulfovibrio) and altered the morphological
structure of the small intestine and colon compared to Normal-control diet (ND) and
Methionine-restricted diet (MRD). The length of the small intestine, the villus height, and the
ratio of villus height to crypt depth in the ileum were significantly reduced (figure1). Colon
was also reduced in overall length and lost the epithelial surface integrity (figure 2).
Interestingly, Methionine-restricted diet (MRD) increased the abundance of inflammation
inhibiting bacteria (Oscillospira and Corynebacterium) and SCFA-producing bacteria,
including Bifidobacterium, Lactobacillus, Bacteroides, Roseburia, Coprococcus, and
Ruminococcus and improved intestinal barrier function (figure 1, 2) (77). Feeding pregnant
mice with a maternal high-fat diet (MHFD) altered the intestine morphology and diversity of
gut microbiota of offspring compared to the maternal-control diet (MCD). The length of villi
and depth of crypts of 3-week old offspring were significantly reduced. This alteration
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disappeared after shifting offspring mice to the control diet after weaning (78). Normal
histologic villi height was found in 36 C57BL/6NTac male mice fed a high-fat diet with or
without exercise. Some increase in width was obvious in obese sedentary mice (OS) that
might be associated with inflammation in obesity (79). However, it has been hypothesized
that gut microbiota may play a functional role in controlling intestinal permeability and
induce barrier structure (80).

Figure1; Demonstrates the influence of ND, HFD, and MRD on the histological
structure of the ileum in a small intestine. The photomicrograph of HFD mice shows a
significant reduction in the villus height and crypt depth in comparison with ND and
MRD photomicrographs (77).

Figure 2; Demonstrates the influence of ND, HFD, and MRD on the histological
structure of the epithelial surface of the colon where displays a loss integrity in HFD in
comparing with ND and MRD (77).
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Conclusion
In summary, the current data indicate that a high-fat diet can alter the diversity and
the abundance of gut-microbiota, particularly the ratio between Firmicutes and Bacteroidetes.
HFD was responsible for an increase in Firmicutes and Proteobacteria with a concomitant
reduction in Bacteroidetes in all wild-type and weight-gain resistant mice (16). A high sugar
and butter (HSB) diet shows a similar influence and changed the Firmicutes/Bacteroidetes
ratio (17). This ratio was modified by consuming a high-sucrose diet (18). The plant-based
diet was associated with high abundance and diversity in microbiotas. In an RCT study, the
consumption of fruits and vegetables caused an increase in Clostridium leptum and
Ruminococcus bromii, genera that is usually reduced in inflammatory bowel disease (IBD)
(23-25). Short-chain fatty acid (SCFA)-producing bacteria (Bifidobacterium,
Lachnospiraceae, and Anaerostipes) and SCFAs production were increased in mice with a
high-fiber diet intake (26). Akkermansia muciniphila, a mucin degrading bacteria, was
increased with the consumption of pomegranate extract, resveratrol, polydextrose, yeast
fermentate, sodium butyrate, and inulin (29). Other diet protocols such as time-restricted
feeding (TRF), probiotics, low-FODMAPs diet, and the Mediterranean diet have also
demonstrated an impact on the gut-microbiome. TRF resulted in an increase in Lactobacillus,
Oscillospira, Ruminococcus, and Firmicutes as well as A. muciniphila, Faecalibacterium
prausnitzii, and Bifidobacteria in another experimental study (34, 36). The reduction of
prebiotics in a low-FODMAPs diet causes a depletion of the gut-microbiota while the
Mediterranean diet needs long-term and high adherence to increase the abundance (44, 46,
48, 49). Probiotics intake can modulate the structure of gut-microbiotas where administrating
Lactobacilli, Bifidobacteria, and Streptococcus can increase their concentration as well as the
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abundance of E. coli and Bacteroides (39). Probiotic fermented milk (PFM) increase
Bacteroides to Firmicutes ratio along the period of intake (41). SCFAs metabolites, including
acetate, propionate, and butyrate, are also functioned as endogenous agonists for several fatty
acid receptors, including GPR41, GPR43, olfactory receptor 78, and GPR109A (50-53).
Each receptor has a specific function such as GPR41 can increase the energy expenditure,
leptin secretion by elevating the gene expression, and decrease the consumption of the foods
(54). The Gut-microbiotas are also involved in regulating the intestinal mucosal immune
response by a number of strategies, including the maintaining mucus layer, secreting
antimicrobial peptide (AMPs), soluble cytokines, IgA, or activating innate lymphoid cells
(ILCs) (59). Diet and microbiome composition may impact the histological structure of the
intestine, where diets, microbiotas, SCFAs, immune cells, and epithelium are interacting with
each other. A recent mice study found HFD altered the gut-microbiome as well as the length
of the small intestine and colon, the villus height, the ratio of villus height to crypt depth in
the ileum, and the epithelial surface integrity of colon (figure 1, 2) (77).
HYPOTHESIS
The influence of diets and timed-restricted feeding protocols on the histological
structure and the immune parameters of the intestine after the change in gut microbiome is
still unknown. Thus, we hypothesize that different diet patterns and time-restricted feeding
strategies that alter the gut-microbiome will result in changes in the morphological and
functional features of different intestinal regions and cellular populations.
Therefore, our study is aimed at:
1) Investigate the differences in the intestinal crypt and villus morphology.
2) Investigate the number and function (proliferation) of intestinal epithelial stem
cells and goblet cells.
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3) Investigating the changes in immune parameters by measuring the expression of
Th-17 and Tregs transcription factors (ROR-γt and Foxp3+), IL-10, IL-6, and TNF-𝛼.

MATERIALS AND METHODS
Animals and Diets
Sixty C57BL/6 male mice were purchased from Envigo (Prattville, Al, USA), and
caged (2-3 mice per cage) at the University of Memphis main campus in accordance with the
U.S. Food and Drug Administration (FDA) guidelines. The healthy control mice were fed a
chow diet (unpurified standard rodent chow; 18% fat, 58% carbohydrates, 24% protein; 3.1
kcal/g) while other intervention mice were fed a high-fat diet (45% fat from lard, 35%
carbohydrate, and 20% as protein) at the beginning of the study and then were subdivided
into six different dietary groups, including 1) Continual-ad libitum high-fat diet 45% (H.F.
45%), 2) switched back to the chow diet (sCHOW), 3) Plant-based diet (59% carbohydrate,
15% protein, and 25% as fat), 4) Calorie-restricted (C.R., 20% of total calories), 5)
Time-restricted feeding (TRF) (6-hours access to foods during the active phase of mice), 6)
Alternate-day fasting (ADF) (alternative days foods access; 24-hours access to foods and
24-hours fasting). The water was provided to all mice without any restriction throughout the
study (table 1) (81, 82). Mice were euthanized after a fourteen-weeks dietary intervention,
and the specimens that will be used in this study were collected and fixed in formalin and
stored at the University of Memphis main campus, Elma Roane Fieldhouse, Lab-room 161.
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Table 1; Displays the macronutrient, caloric density, and nutrient compositions of the
experimental diets of both Daniel Fast (DF) and High-Fat (HF) diets (81, 82).
Composition of Purified Diets

HF

DF

Macronutrients
Protein

kcal%
20

kcal%
15

Carbohydrate
Fat
Energy kcal/g

35
45
4.73

59
25
3.9

Ingredients
Casein, 80 mesh
Soy protein

g
200
0

g
0
170

dl-Methionine
l-Cysteine

0
0

3
3

Sucrose
Corn starch
Maltodextrin 10

172.8
0
100

0
72.8
150

Corn-Starch-Hi Maize 260 (70%/30% ratio of
Amylose/Amylopectin)
Cellulose, BW200

0

533.5

50

100

Inulin

0

50

Soybean oil

25

0

Lard

177.5

0

Flaxseed oil

0

71

Safflower oil, high oleic

0

59

Mineral mix S10026

10

35

Calcium carbonate

5.5

4

Potassium citrate

16.5

0

Dicalcium phosphate

13

0

Vitamin mix V10001

10

10

Choline bitartrate

2

0
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Histology
Tissue Processing
The data have been collated from the fixed stored specimens (proximal, mid, distal
intestine, and colon) from September 2019 to September 2020, at the University of Memphis,
School of Health Studies (SHS). The tissues were processed as follows; dehydration by
immersing the specimens twice in 70% and then 90% ethanol for 15 minutes each time. The
samples were further dehydrated by submerging in 100% ethanol for 15, 15, 30, and 45
minutes every time. Ethanol was then cleared from tissues with histoclear (HISTO-CLEAR
II, # 64111-04, Electron Microscopy Sciences, USA) by submerging the specimens twice for
20 and 45 minutes. Tissue were then infiltrated with molten paraffin waxes (Paraplast X-tra,
#39603002, Leica Biosystems, USA) at 60 C; for 30, 30, and 45 minutes each
time,respectively. Embedding followed the paraffin infiltration to build a block of paraffin
wax around the tissues to provide a support matrix. The small intestine and colon were cut in
5 μm thickness, according to a previous study (77). Charged slides (Shandon Superfrost™
Plus, # 6776214, Thermo Scientific™, USA) were used to improve the tissue adhesion on the
slices and to reduce the chance of damaging and washing off the tissues during the process of
the next stage (staining). Lastly, the slices should be kept to dry for a few hours at the room
temperature for staining.
Hematoxylin and Eosin (H&E)
Hematoxylin and Eosin (H&E) dyes were used for the purpose of making the tissues
structures visible under the microscope. The protocol that was followed starts with
deparaffinized. The slides immersed twice in 100% histoclear for 3 minutes each time, and
then once in histoclear: ethanol (1:1 with 50% concentration) for 3 minutes as well; to
remove the paraffin wax. The slides then dehydrated by soaking them in ethanol with
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different concentrations (100%, 95%, 70%, and 50% respectively; for 3 minutes every time).
Thereafter, slides were washed in deionized water, once before and twice after incubating the
slides in a hematoxylin (Hematoxylin+, # 220-100, Fisher HealthCare, USA) for 3 to 5
minutes. The slides then dipped 10-times in 95% ethanol, followed by immersing in eosin
stain (Eosin Y-Solution 0.5% Alcoholic, For Microscopy, MilliporeSigma™, Fisher
Healthcare, USA) for a minute. Dehydration then takes place by using ethanol. The slides
were doused in 95% and 100% ethanol from 6 to 10 times, followed by a dip in histoclear:
ethanol (1:1 with 50% concentration). Finally, the slides were cleared in absolut 100%
histoclear for a minute and then left to dry before adding mounting medium (Permount
Mounting Medium, #17986-05, Electron Microscopy Sciences, USA) over the tissue
specimens and covered with slips for protection.
Periodic Acid-Schiff (PAS)-Alcian Blue (AB)
Alcian blue stain at pH 2.5 (Alfa Aesar™ Alcian Blue 8GX, #AAJ6012209, Fisher
Healthcare, USA) was utilized for counting the goblet cells, due to the acidic nature of mucin
in goblet cells. The tissue sections for the distal part of the small intestine and colon were
first deparaffinized in histoclear and graded ethanol. The slides were immersed twice in
absolute histoclear, and then once in histoclear: ethanol (1:1 with 50% concentration); for 3
minutes each time. Followed by soaking them in graded ethanol (100%, 95%, 70%, and
50%; respectively), for 3 minutes, in each wash. The slides then were hydrated in distilled
water (one-dip) and incubated in 3% glacial acetic acid solution for 3 minutes. Followed by
30-minute incubation in alcian-blue stain solution (1% alcian blue in 3% glacial acetic acid;
pH 2.5). The tissue sections were then washed in running tap water for 2-5 minutes and
dipped twice in distilled water before and after the incubation in Nuclear Fast Red Solution
(Nuclear Fast Red Solution,# TS10-500, Tyr Scientific LLC, USA). Finally, the sections

21

were dehydrated in 95% and 100% Ethanol ( 6-10-dips), and clear in histoclear: ethanol
(one-dip) and absolute histoclear for 1 minute before covering with mounting medium and
slips.
Histological Data Collection
The images of the stained slides were captured and collected at Room-Lab 161 in
Fieldhouse, by EVOS™ M7000 Imaging System from Invitrogen by Thermo Fisher
Scientific. Morphological differences in villi length and crypt depth were analyzed by
Invitrogen Celleste Image Analysis Software (SKU# AMEP4816) from Thermo Fisher
Scientific.
H&E
Invitrogen Celleste Image Analysis ( SKU# AMEP4816, Thermo Fisher Scientific)
Software was used to measure the differences in villi length and crypt depth among the
tissues. Ten to eighteen measures were taken from each mouse at the proximal, mid, distal,
and colon region (Figure 3). The mean of each animal was then determined. For the
Chow-Control Diet (CC), the measures of small intestine sections and colon were taken from
seven samples, while the measures were taken from eight samples in Switch to
Chow-Control Diet (SW-C). In the High-Fat Diet (HFD) and Plant-Based Diet (DF), eight
proximal, distal, and colon were used for taking the measurements in HFD, while six
proximal, seven mid and distal, and eight colon were utilized in DF. Seven proximal and mid,
and eight distal and colon were measured for collecting data in Caloric-Restricted Diet (CR),
while eight proximal, seven mid, and nine distal and colon were applied in Time-Restricted
Feeding (TRF). Finally, in Alternate Day Fasting (ADF), eight proximal and colon, seven
mid, and six distal were used for collecting data of villi length and crypt depth (table 2).
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Table 2; The Number of Total Samples Were Used for Data Collection in H&E
Feeding Group | Intestinal Part

Proximal

Mid

Distal

Colon

Chow-Control Diet

7

7

7

7

Switch to Chow-Control

8

8

8

8

High-Fat Diet (HFD)

8

7

8

8

Plant-Based Diet (DF)

6

7

7

8

Caloric-Restricted Diet

7

7

8

8

Time-Restricted Feeding

8

7

9

9

Alternate Day Fasting

8

7

6

8

Table 2: Shows the number of tissue specimens that were used for collecting data for
the purpose of measuring the villi length and crypt depth in each group and sections.
Ten to eighteen measures were taken from multiple pictures of each tissue sample.

Figure 3 shows the method of measuring the villi length and crypt depth in all
small intestine sections and colon. In Figure 3.A, the tow tall lines on the left
side of image A represent the way of measuring the villi length in the small
intestine, as well as the three short green lines on the right side of image A
represent the method of measuring the depth of the crypt. In Figure 3.B, black
lines demonstrate how the length of villi was taken in colon sections, as well as,
green lines show the methods of measuring the crypt.
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Periodic Acid-Schiff (PAS)-Alcian Blue (AB)
The distal portion of the small intestine and colon were the only tissue sections
studied for the ratio of goblet cells. Due to the results in the same study (published
previously) showed that most changes in metabolites and microbiomes were in the distal and
colon sections (82). The Goblet Stained Cells (GSCs) in villi and crypt were counted by
Tally Counter. Three measures were counted from various four longitudinal villi of each
tissue sample, and other three measures were calculated from the same crypt of the four
longitudinal villi. The mean of each animal was then determined. The number of samples
that were utilized in collecting the data varied between six to nine (table 3).
Table 3; The Number of Total Samples Were Used for Data Collection in PAS-AB stain
Feeding Group | Intestinal Part

Distal

Colon

Chow-Control Diet

7

7

Switch to Chow-Control

8

8

High-Fat Diet (HFD)

7

8

Plant-Based Diet (DF)

7

8

Caloric-Restricted Diet

6

8

Time-Restricted Feeding

9

9

Alternate Day Fasting

6

8

Table 3: Shows the number of tissue specimens that were used for collecting data for the
purpose of counting the goblet cells in villi and crypt in each group and sections. Three
different measures were taken from villi and crypt from multiple pictures of each tissue
sample.
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Figure 4 Shows a representative image to show how the Goblet Cells (GCs) were
counted in villi and crypt. In figure 4.A, the parentheses from 1 to 2 indicate the four villi
where GCs were counted, and the parenthesis 3 shows where GCs were counted in the
crypt; in all small intestine sections. In figure 4.B, arrows 1 demonstrates where the GCs
were counted in the crypt of colons, as well as arrows 2 displays the GCs in villi.

Reverse transcription polymerase chain reaction (RT-PCR)
RNA Isolation
RNAs were isolated from the frozen-stored intestinal tissues for RT-PCR. The
protocol contains five steps,homogenization, phase-separation, RNA precipitation, RNA
wash, and RNA solubilization. For homogenization, 1 ml of Trizol (TRIzolTM Reagent, #
15596018, invitrogen, USA) was added to 50-100 mg of disrupted tissues, and homogenized
by a Polytron homogenizer (kinematica homogenizer, POLYTRON # PT 1200 E). The
mixture was then incubated for 5 to 10 minutes in a room-temperature (RT). During this
stage, the sample value should not exceed 10% of the value of the TRI Reagent RT. 50 µl of
4-bromoanisole (BAN Phase Separation Reagent, # BN 191, Molecular Research Center,
Inc., USA) per 1 ml of Trizol (TRI Reagent RT) was added for the phase-separation. The
mixture was then mixed vigorously for 15 seconds, and centrifuged at 13,000g for 15
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minutes at 4℃. The RNAs are in the colorless-aqueous phase in the microcentrifuge
tubes.The RNA precipitation then takes place by adding 0.5 ml isopropanol (2-Propanol
(HPLC), Fisher Chemical™, # A451-4, Fisher Scientific, USA) to 0.5 ml of a
colorless-aqueous phase. Mix the mixture well by inverting the tube before the RT-incubation
for 5-10 minutes and then centrifuged at 13,000g for 10 minutes at 4℃. The RNAs
precipitate in the form of gel-like or white pellet on the bottom or side of the tube after the
centrifugation. The supernatant was removed, and the RNAs pellet was washed with 1 ml of
75% ethanol by vortexing. Afterward, centrifuge it at 7500 g for 5 minutes at 4℃. Finally,
the supernatant (ethanol wash) was removed, and 30µl Hy-Pure water will be added for
RNAs solubilization for 5-10 minutes at the RT. For better RNA dissolving, vortex, or pass
the solution through the pipette tip a few times.
Single-stranded cDNA Synthesis
The Applied Biosystem High Capacity RNAs to cDNAs kit (# 4387406,
ThermoFisher Scientific, USA) was used to synthesize cDNAs from total RNAs. Up to 2 μg
of total RNAs were used per 20-μL reaction. 2X RT Buffer, 20X RT Enzyme Mix,
Nuclease-free H2O, and Total RNA sample were mixed with volumes of 10.0 μl, 1.0 μl, 1.0
μl, and 8.0 μl; respectively. The RT-reaction mix was then aliquot into strips of eight PCR
tubes and sealed appropriately for a short centrifuge to spin down the contents and eliminate
any air bubbles. Finally, the PCR tubes were placed in the thermocycler for the reverse
transcription, where thermocycler was programmed the reaction volume to 20 μl at 37°C for
60 minutes to incubate the reaction, 95°C for 5 minutes to stop the reaction by heating, and
4°C for hold. The resulting cDNAs were ready for RT-qPCR or stored for a long time in a
freezer at −25°C to −15°C.
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Real-Time qPCR
Non-specific detection, SYBR Green (PowerUp™ SYBR™ Green Master Mix, # A25741,
ThermoFisher Scientific, USA) was used for Real-Time PCR. The initial screen measured
the expression levels of ROR-γt, Foxp3+, IL-10, IL-6, and TNFα. We decided to focus on
measuring the level of ROR-γt and Foxp3+ expression based on higher expression levels
detected in our tissues. The RT-PCR components, including Sybergreen mix, Forward primer,
Reverse primer, Total cDNA, and nuclease-free H2O, will be first thawed on ice, and the
cDNA reaction mix was be diluted to ten folds by adding 180 μl nuclease-free H2O. The
RT-PCR components were then mixed at volume 7.5 μl for the Sybr Green mix, 0.75 μl for
both forward and reverse primers, 5 μl for total cDNA, and 1 μl for nuclease-free H2O. The
primers that were used for ROR-γt are, forward 5′-AAGTACCACAATATGCGACCC-3′ and
reverse 5′-TCTGAAGTAGGCGAACATGC-3′ and FOXP3, forward
5′-TTTCTGAGGATGAGATTGCCC-3′ and reverse
5′-TTGTCGATGAGTCTTGCAGAG-3′. The primers of IL-10 are forward,
5′-AGCCGGGAAGACAATAACTG-3′ and reverse
5′-GGAGTCGGTTAGCAGTATGTTG-3′, IL-6 forward,
5′-CAAAGCCAGAGTCCTTCAGAG-3′ and reverse 5′-GTCCTTAGCCACTCCTTCTG-3′,
and TNF-𝛼 forward, 5′-CTTCTGTCTACTGAACTTCGGG-3′ and reverse:
CAGGCTTGTCACTCGAATTTTG-3′.β-actin was the control gene (the high expressed
endogenous mRNAs) with a forward primer 5′-ACCTTCTACAATGAGCTGCG-3′ and
reverse 5′-CTGGATGGCTACGTACATGG-3′. Finally, the reaction was run in the RT-qPCR
thermocycler (Applied Biosystems QuantStudio 6 Flex Real-Time PCR System, Serial
#278861981, Thermo Fisher Scientific) by using the RT- program (QuantStudio™ Real-Time
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PCR Software), and the cycle threshold (CT) values calculated by comparing the genes of
interest (ROR-γt and Foxp3+) with the internal control/Gapdh (β-actin).
STATISTICAL ANALYSIS
Statistical analysis was performed using GraphPad Prism version 8. Data are
presented as means ± SD and P-values less than 0.05 were considered statistically
significant. All data sets were tested for homogeneity of variance by using the Brown-Forsythe test.
One-way analysis of variance (ANOVA) was conducted for comparing the data from all variables.

RESULTS
1- Villi Length:
1.1. Proximal Sections
H&E stained sections were used to measure villi length in the proximal, mid, and
distal regions of the small intestine and also in the colon. In the proximal region, the
conducted analysis of One-Way ANOVA shows a statistically significant difference
(P=0.0283) among the feeding groups. Post hoc comparisons using the Tukey procedure
reveals that Chow-Control (CC) has the longer proximal villi average with a mean = 507.3 ±
83.5 µm in comparison with other interventional feeding groups. As indicated on figure 5,
statistical significant differences were detected for CC vs for Plant-Based (DF, mean = 374.7
± 72.43 µm, P=0.03) and Alternate-Day Fasting (ADF, mean = 388.6 ± 55.36 µm, P =
0.0388). No significant differences were detected in a proximal villi length between the
SW-C (437.7 ± 92.14 µm, P=0.5110), CR (mean = 454.1 ± 100.8 µm, P=0.8083), and TRF
(mean = 451.1 ± 38.54µm, P=0.7387). The plant-based diet (DF) was the shortest amongst
all feeding groups 374.7 ± 72.43 µm. (Figure 5B).
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1.2. Mid Sections
No significant differences were detected in villi length in the mid section of the small
intestine (P=0.1790). However, all groups consuming the high-fat diet and also DF groups
had shorter villi than the chow consuming groups (CC and SW-C, Figure 5C).
1.3. Distal Sections
In distal sections, where the most change in the small-intestinal microbiome was seen
(82), a significant difference exists among the means (P<0.0001). The group of HFD and
ADF groups had a significant reduction in villi length in comparison to all Chow-control
groups (CC, mean= 323.8 ± 36.00 µm vs. HF, mean= 212.1 ± 25.97 µm; P0.0001), (SW-C,
mean= 274.9±41.99 µm vs. HF, mean= 212.1± 25.97 µm; P=0.0374), (CC, mean=
323.8±36.00 µm vs. ADF, mean= 177.9±24.18 µm; p<0.0001), and (SW-C, mean=
274.9±41.99 µm vs. ADF, mean= 177.9±24.18 µm; p = 0.0007). The CC groups also had
significantly longer villi than DF (P=0.0012), CR (P=0.0017), and TRF (P=0.0002).
Although not significant, the length of distal villi of DF (mean= 231.5 ± 55.68 µm) is slightly
longer than HFD (mean= 212.1 ± 25.97 µm; p=0.9613), TRF (224.4 ± 38.31 µm; p=0.9998),
and ADF (177.9 ± 24.18 µm; p=0.1997) (Figure 5D).
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A. Histological Images:
Proximal

MID

Distal

CC

Figure 5; (A). Representative images of H&E stained cross-section of the proximal, mid, and
distal small intestine from a control C57BL/6 male mouse that consumed the chow diet. The
villi length in Proximal (B), Mid (C), and Distal (D) regions of the small intestine of groups
on different diets or timed feeding protocols. Values are mean ± SEM, n = 6-9 per group.
In (D), *P<0.0001, CC vs. HFD; **P= 0.0012, CC vs. DF; ***P= 0.0017, CC vs. CR;
****P= 0.0002, CC vs. TRF; *****P= <0.0001, CC vs. ADF; #P= 0.0374, HFD vs. SW-C;
##P= 0.0007, SW-C vs. ADF.
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1.4. Colon Sections
An analysis of the villi length in the colon detected significant group differences
(P<0.0001). Similar to feeding-induced changes in the small intestine, the ad libitum high-fat
diet had the most significant reduction in the villi length (P<0.0001, HF vs. CC), where HF
(122.7 ± 22.02 µm) was only 64.17% of the villi in the CC group (191.2 ± 18.24 µm). DF
group had the most significant increase in villi length (P= 0.0021, DF vs. CC), where DF
(153.9 ± 7.964 µm) was 80.49% of villi in the CC group (191.2 ± 18.24 µm). However, all
groups consuming the high-fat diet had shorter villi than the chow consuming groups (CC
and SW-C). A statistical significant differences were detected CC vs. for Caloric Restricted
(CR, mean= 149.2 ± 9.461 µm, P=0.0004), Time-Restricted Feeding (TRF, mean = 123.5 ±
19.68 µm, P<0.0001), and Alternate-Day Fasting (ADF, mean= 125.6 ± 23.82 µm,
p<0.0001). Also SW-C vs. HFD (P<0.0001), CR (P= 0.0236), TRF, and ADF (P<0.0001). As
indicated on figure 6, the DF group also had significantly longer villi than, HFD (P=0.0120),
TRF (P= 0.0115), and ADF, (P= 0.0299).
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A. Histological Images:
Colon

CC

Figure 6; (A). Representative images of H&E stained cross-section of colon from a control
C57BL/6 male mouse that consumed the chow diet. (B). Villi length in colon section of
groups on different diets or timed feeding protocols. Values are mean ± SEM, n = 7-9 per
group.
# p<0.0001, SW vs. HFD, TRF, and ADF; p = 0.0236, SW-C vs. CR.

2- Crypt Depth:
2.1. Proximal Sections
We next analyzed crypt depth. Significant differences in crypt depth were detected in
the proximal region of the small intestine P=0.008). HFD, TRF, and ADF groups had
significantly shorter crypt depth than CC (CC, mean= 85.75 ± 12.59 µm vs. HFD, mean=
51.36 ± 3.406 µm, P=0.0177; TRF, mean= 52.65 ± 4.102 µm, P=0.0252; ADF, mean= 51.79
± 4.680 µm, p= 0.0200). Although not significant, there was an association in length
depending on the diet consumed with DF (mean= 71.99 ± 53.92) group having taller crypts
than all HF consuming groups. (Figure 7B).
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2.2. Mid Sections
The mid-sections demonstrate statistically significant differences in depth of crypt
(P<0.0001), The largest differences are between the HF diet consuming groups HFD (mean=
50.46 ± 14.67 µm), CR (mean= 47.64 ± 2.504 µm), TRF (mean= 44.85 ± 5.684 µm), and
ADF (mean= 48.24 ± 4.648 µm) vs. CC (mean= 80.36 ± 11.99 µm, P<0.004). Also, SW-C
(mean= 68.2 ± 6.908 µm) shows significant difference with TRF (P=0.0259). There were no
statistically significant differences between CC vs. DF, and CC vs. SW-C (CC, mean= 80.36
± 11.99 µm vs. DF, mean= 65.69 ± 29.89 µm, p= 0.4377; and SW-C, mean= 68.2 ± 6.908
µm, P=0.6740), suggesting that the high-fat diet resulted in decreased crypt depth in the
mid-small intestine. (Figure 7C).
2.3. Distal Sections
The most significant changes in crypt depth were detected in the distal small intestine
(P<0.0001). There was 40-54% reduction in crypt depth between CC (mean= 85.55 ± 10.95
µm), and the high fat consuming groups; CC vs HFD (mean= 46.02 ± 5.917 µm, P<0.0001),
CR (mean= 50.17 ± 3.641 µm, p<0.0001),TRF (mean= 45.74 ± 4.320 µm, p<0.0001), and
ADF (mean= 39.28 ± 4.140 µm, P≤0.0001). The animals that were switched to the chow diet
after high-fat diet consumption showed recovery of crypt depth in the distal region, and
showed significant differences between SW-C (mean= 68.05 ± 4.674 µm) vs. HFD, CR, and
TRF, P<0.0001). There was also a significant difference between chow consumed groups
(CC and SW-C) and DF (mean= 54.29 ± 7.027 µm) P<0.002. Significant differences were
also detected between ADF vs. DF and CR, p<0.031. (Figure 7D).
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A. Histological Images
Proximal

Mid

Distal

CC

Figure 7; (A). Representative images of H&E stained cross-section of the proximal, mid, and
distal small intestine from a control C57BL/6 male mouse that consumed the chow diet. The
crypt depth in Proximal (B), Mid (C), and Distal (D) regions of the small intestine of groups
on different diets or timed feeding protocols. Values are mean ± SEM, n = 6-9 per group.
**CC significantly different from all high-fat and DF groups p<0.0001. ## SW-C
significantly different from all high-fat (p<0.001), and DF (p= 0.0015) groups.
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2.4. Colon Sections
Within the colon, statistical significant differences were detected between different
diet and feeding groups ( P <0.0001). All high fat-consuming animals had significant
reductions in the crypt depth (P<0.0001), where 61.41- 46.48 % of reduction were detected
between CC (mean= 111.0 ± 11.48 µm) vs. HFD (mean= 51.69 ± 7.394 µm), CR (mean=
67.87 ± 10.17 µm), TRF (mean= 51.60 ± 9.108 µm), and ADF (mean= 64.77 ± 25.77 µm).
There was also a statistical significance between CC and DF (mean= 75.56 ± 10.74 µm;
P=0.0002). This change in crypt-depth is confirmed when the animals in High-Fat Diet
groups shifted back into the Chow-Control diet. They showed recovery of crypt depth in the
colon region, and showed significant differences between SW-C (mean= 88.73 ± 14.39 µm)
vs. HFD, TRF, and ADF; P<0.02. Similarly, DF had a comparable effect and significantly
increased the depth of colon crypt in HFD (P=0.0194) and TRF groups (P=0.0142). (Figure
8).
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A. Histological Images

Colon

CC

Figure 8; (A). Representative images of H&E stained cross-section of colon from a control
C57BL/6 male mouse that consumed the chow diet. (B). The crypt depth in colon section of
groups on different diets or timed feeding protocols. Values are mean ± SEM, n = 7-9 per
group.
In B, ** CC significantly different from all high-fat (p<0.0001), SW-C (p= 0.0477), and DF
groups (p= 0.0002).
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3- Number of Goblet Cells (GCs) in Distal Sections of Small Intestine
3.1. Number of Goblet Cells in Villi
We further analyzed the number of Goblet Cells (GCs) using Periodic Acid-Schiff
(PAS)-Alcian Blue (AB) stain. No significant differences in the number of goblet cells were
detected in villi region of the distal of the small intestine (P= 0.1021). Although not
significant, there was a clear reduction in the number of goblet cells in the ADF group than
other groups on a diet or timed feeding protocols (CC, mean= 46.00 ± 7.364 µm; SW-C,
mean= 52.38 ± 14.73 µm; HFD, mean= 50.29 ± 20.25 µm; DF, mean= 52.71 ± 15.11 µm;
CR, mean= 46.50 ± 8.310 µm; TRF, mean= 53.22 ± 9.529 µm; ADF, mean= 33.89 ± 4.251
µm). (Figure 9B).
3.2. Number of Goblet Cells in Crypt
In the crypts, significant differences were detected in the number of goblet cells
(P=0.0045). The animals that were switched to the chow diet after high-fat diet consumption
showed a significant increase in the number of goblet cells in crypt of distal sections of small
intestine (SW-C, mean= 63.42 ± 14.71 µm vs. HFD, mean= 38.86 ± 12.74 µm, P=0.0019;
CR, mean= 44.44 ± 13.31 µm, P=0.0418; ADF, mean= 42.39 ± 7.567 µm, P=0.0172). As
indicated in figure 9, the group that consumed HFD had the lowest number of goblet cells of
all the intervention groups (CC, mean= 47.33 ± 7.518 µm, HFD, mean= 38.86 ± 12.74 µm,
SW-C, mean= 63.42 ± 14.71 µm, DF, mean= 47.24 ± 7.788 µm, CR, mean= 44.44 ± 13.31
µm, TRF, mean= 48.19 ± 10.82 µm, and ADF, mean= 42.39 ± 7.567 µm). (Figure 9C).
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A. Histological Images

Distal

CC

Figure 9; (A). Representative images of PSA stained cross-section of the distal of the small
intestine from a control C57BL/6 male mouse that consumed the chow diet.The number of
GCs in distal-villi (B), and crypt (C) section of groups on different diets or timed feeding
protocols. Values are mean ± SEM, n = 6-9 per group.
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4- Number of Goblet Cells (GCs) in Colon Sections
4.1. Number of Goblet Cells in Villi
The PAS staining showed no differences in the number of goblet cells in the villi of
colons. However, as indicated in figure 10B, DF had a higher number of GCs than other diets
or timed feeding protocols (DF, mean= 10.21 ± 2.462 µm; CC, mean= 6.619 ± 2.505 µm;
SW-C, mean= 7.208 ± 3.408 µm; HFD, mean= 7.875 ± 3.013 µm; CR, mean= 8.667 ± 3.376
µm; TRF, mean= 7.630 ± 2.170 µm; and ADF, mean= 9.333 ± 4.393 µm). (Figure 10B).
4.2. Number of Goblet Cells in Crypt
Within the crypts, significant group differences were detected for the number of GCs
(P<0.0001). Similar to feeding-induced changes in the crypt section of the small intestine, the
plant-based diet (DF) had the most significant increase in the number of goblet cells of
crypt-colon (DF, mean= 40.50. ± 5.014 µm vs. CC, mean= 31.19 ± 3.442 µm, P= 0.0063;
HFD, mean= 29.21 ± 7.536 µm, p= 0.0003; SW-C, mean= 32.92 ± 3.833 µm, p= 0.0337;
CR, mean= 29.83 ± 4.047 µm, p= 0.0007; and ADF, mean= 28.63 ± 3.897 µm, p= 0.0001).
Although not significant, the number of GCs in the crypt of colon of DF (mean= 40.50. ±
5.014 µm) are slightly higher than TRF (mean= 34.19 ± 3.749 µm). (Figure 10C).
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A. Histological Images

Colon

CC

Figure 10; (A). Representative images of PSA stained cross-section of the colon from a
control C57BL/6 male mouse that consumed the chow diet.The number of GCs in colon-villi
(B), and crypt (C) section of groups on different diets or timed feeding protocols. Values are
mean ± SEM, n = 7-9 per group.
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5- The Expression level of the Immune Parameters:
5.1. Foxp3+
The level of Foxp3+ expression was determined in the distal section of the small
intestine by using qPCR. No significant group differences in the level of expression of the
transcription factors Foxp3+ (P= 0.3422). Even though no significant indicated, the
expression of Foxp3+ was higher in the animals that consumed DF and HFD than all groups
consuming chow diet or on time-restricted feeding protocols (DF mean= 0.0007358 ±
0.0003414 and HFD mean= 0.0007284 ± 0.0008299 vs. CC mean= 0.0004843 ± 0.0004643,
SW-C mean= 0.0005386 ± 0.0003350, CR mean= 0.0001705 ± 7.235e-005, TRF mean=
0.0003674 ± 0.0002170, and ADF mean= 0.0006426 ± 0.0005627). (Figure 11A).
5.2. RORγt
Levels of expression of RORγt were also determined in the distal portion of the small
intestine by qPCR. Although not significant differences were detected (P=0.3642), all the ad
libitum high-fat diet groups had the highest level of expression of intestinal RORγt than
chow and DF diets (HFD mean =0.07165 ± 0.05304, CR mean= 0.06844 ± 0.04231, TRF
mean= 0.05358 ± 0.02479, and ADF mean= 0.06565 ± 0.04889) vs. (CC mean= 0.03939 ±
0.005165, and SW-C mean= 0.02830 ± 0.009448). Interestingly, similar to feeding-induced
changes in the Foxp3+, the DF diet had a lower expression level of the transcription factors
RORγt (DF mean= 0.04526 ± 0.04665). (Figure 11B).
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Figure 11; Representative the expression level of Foxp3+ (A), and RORγt (B) in the distal
section of the small intestine for C57BL/6 male mouse on different diets or timed feeding
protocols. Values are mean ± SEM, n = 6 per group.
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DISCUSSION
The human gastrointestinal tract (GIT) is the most densely colonized area within the
human body. It contains approximately 100 trillion microorganisms with bacteria being the
most abundant organisms. The microbiome, which is the combined genome from these
microorganisms, contains a 100 times more genes than their human hosts (3, 4, 8). Diet is the
biggest determinant of the composition of the intestinal microbiome and its metabolites and
their communication with the gut mucosal immune system and intestinal epithelial cells (2,
4, 7). Changes in diet and microbiome have also been shown to alter the morphological
structure of the intestine and dysregulate the response of the mucosal immune cells (59, 77,
80). The consumption of an ad libitum high-fat diet by C57BL/6 male mice mimics the
metabolic dysfunctions seen in humans, and makes this an appropriate model for testing the
influence of different dietary protocols and restricted feeding protocol on gut microbiota and
its implications intestinal morphology and health.
We had previously published the changes induced in the microbiome by the feeding
protocols used in this study (82). To further understand the interaction between
feeding/fasting, the microbiome and intestinal morphology we determined the average of
villi length and crypt depth in both the small intestine (proximal, mid, and distal regions)
and colon section. Villi length in the proximal region showed no major difference, and the
mid-region of the small intestine was not significantly different between groups. The high
fiber diet group (DF) was the shortest of all groups in the proximal region. Interestingly, this
is also the region of the small intestine where very little difference in the microbial
alpha-diversity was observed. In the distal region a significant reduction in villi length was
seen in all groups fed with HFD, with no difference between the ad libitum HF and fasted
groups. The length of distal villi was restored after shifting the animals back to the chow
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diet. Although distal microbiome data was not collected, microbiome and SCFA analyis was
performed on the cecal content which is immediately adjacent to the distal small intestine
and both the Chow control and switch to Chow groups had increased alpha-diversity and
were similar in terms of beta-diversity. There were also changes in specific phyla; the high
fat diet groups all had high levels of Firmicutes and reduced Bacteroidetes as compared to
chow consuming animals.(Unpublished data van der Merwe lab). This is consistent with
other studies, in balb/c mice the villi length was significantly decreased in HFD in
conjunction with a significant increase in fecal population of Firmicutes to the Bacteroidetes
(83). A recent study shows also relevant findings where a high-fat diet increased Firmicutes
at the phylum and reduced the villi height. In addition, the Verrucomicrobia phylum level
decreased in animals consuming a HF diet, our previous work showed that the high-fiber DF
group increased the level of the Verrucomicrobia phylum (77, 82). It's worth a mention that
DF had slightly longer villi than HFD, TRF, and ADF.
Changes in the colon villi length mirrored that seen in the distal region of the small
intestine with the HFD group having the most significant reduction in villi length followed
by the high fat fed groups, TRF and ADF. The villi length in the Daniel Fast group was not
recovered to the extend that the Sw-Chow is, but it is significantly larger than most HF fed
groups. The phylum-level of Firmicutes to the Bacteroidetes was extremely high (HFD
56:17%, CR 54:16%, TRF 49:20%, and ADF 54:14%), while the chow and DF fed diet
resulted in a similar bacterial composition with lower Firmicutes and higher Bacteroidetes,
suggesting microbiome dysbiosis may contribute to the change in villi length (82). This
result is consistent with db/db mice altered the colon villi length significantly along with an
increased Firmicutes level and decreased in both Bacteroidetes and Verrucomicrobia (34).
Verrucomicrobia (A. muciniphila) and Bacteroidetes was increased in the DF group (82). The
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mucus-associated A. muciniphila and Bacteroidetes have been linked to the high-fiber diet in
multiple studies (29). This relationship between microbiome, plant-based high-fiber diet, and
villi length confirmed when HF animals shifted back into a chow diet (SW-C) and increased
the length of villi significantly.
We also investigated the correlation upon various dietary or timed-restricted
strategies, gut microbiome, and the alteration in intestinal morphology by evaluating the
average of crypt depth of both small intestine and colon. Crypts are dynamic structures that
change postnatally. The architecture of crypts provides multiple functions; protection of stem
cells from luminal content and the ability to package the required number of amplifying
cells. It is also suggested that crypt morphology is in general important for tissue architecture
(84). In the small intestine, both sections of proximal and mid had a significantly shortened
crypt depth in most high-fat consumed groups in comparison to CC groups. DF group was
not statistically significantly shorter than chow control group which suggests that the
high-fat diet resulted in decreased the crypt depth in proximal and mid sections of the small
intestine. A possible explanation for our findings is that the dietary component of a
plant-based diet modulates the gut microbiome and intestinal morphology as seen in broilers
(85). Similar to feeding-microbiome-induced changes in distal-villi length, the crypt depth
was significantly reduced in all groups fed a high-fat diet. Consistent with results from high
fat fed rats demonstrating a reduction in the crypt depth and an increase in abundance of the
phyla Firmicutes (86). Throughout the small intestine, the switch to chow and DF group had
recovered the crypt depth. The recovery in crypt depth in the DF group might be due to a
specific increase in the mucin-degrading bacteria (A. muciniphila) that was greatly expanded
in this group. Akkermansia muciniphila was found to improve the general morphology and
intestinal barrier in germ-free mice (87).

45

Similar to villi length, the colon crypt depth mirrored that seen in the distal region of
the small intestine. All ad libitum high-fat consuming groups had significant shortness in the
colon crypt. These results have also been observed in rats where consumption of a HF diet
decreased the crypt-depth from 160 ± 3.9 µm to 132.3 ± 6.3 µm (86). The increase in
Firmicutes to the Bacteroidetes ratio was also linked to the HF diet induced changes in
several studies (16, 18, 82).
To further investigate the effect of different diets and timed feeding protocols on
intestinal function, we evaluated the number of goblet cells distal of small intestine and
colon. No significant change in goblet cell number was observed in the villi of either the
distal region of the small intestine or colon. However, there were significant differences in
the crypt within the distal small intestine. All high-fat groups had a reduction in the number
of GCs except TRF consistent with previously published results showing that a HFD resulted
in significantly decreased PAS-positive goblet cells in the ileal region of the small intestine
(88). The DF showed no difference in the number of GCs in both distal villi and crypt. The
most dramatic increase in GCs was seen in the crypt region within the colon. These interfere
with our previous/published findings where DF slightly increased villi length, crypt depth,
and the phylum level of Verrucomicrobia (A. muciniphila). The growth of Verrucomicrobia
(A. muciniphila) in the intestine depends on the excretion of mucin from goblet cells (89). A
potential explanation for this is that A. muciniphila is more abundant in the colon (90). This
goes in line with our published data of the same study where the percentage of
Verrucomicrobia was high in the colon sections of the DF group (82). This increase in
colonic mucin levels was later confirmed by periodic acid Schiff (PAS) staining. In addition,
a high-fiber/plant-based diet showed a similar effect in Wistar rats, where no significant
alteration in small intestinal mucin and most of the change was in the colon (91).
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In the colon, the high-fiber (DF) diet resulted in dramatic increase in goblet cells in
both the villi and crypt consistent with our findings of colon villi length and crypt depth. DF
had also decreased the cecal level of Firmicutes consistent with an increase in Bacteroidetes
and Verrucomicrobia from 1% in HFD to 17% (82). As mentioned above, the growth of
Verrucomicrobia (A. muciniphila) mainly depends on the excretion of mucin from goblet
cells (89), suggesting Akkermansia muciniphila could increase the number of goblet cells.
The colonization of A. muciniphila had previously been found to increase in the number of
goblet cells independently of diets (92). The level of MUC2 expression and the number of
goblet cells were high along with the increase in mucin degrader Akkermansia (93).
Finally, we evaluated the role of diet and fasting on gut immunity by measuring the
transcript levels of Foxp3+ and RORγt in the intestinal tissue. We initially also determined
the expression levels of various cytokines, but due to low expression we decided to focus on
the transcription factors Foxp3 and RORγt. Foxp3 and RORγt are both playing critical roles
in immune homeostasis. The expression of Foxp3+ leads to differentiation of the regulatory
T cells that are essential for immunological tolerance, while the inflammatory Th17 cells are
directly differentiated by RORγt. Foxp3+ can also regulate Th17 differentiation by binding
directly to RORγt protein and antagonize the binding into the DNA (94). The expression of
RORγt in Tregs can enhance the suppressive capacity of Tregs and make the Foxp3+RORγt+
T cells subset effective in alleviating the intestinal inflammation (95). Although no
significance was detected for either transcription factors, interesting trends were observed.
DF induced an insignificant expression of Foxp3+. Both the HF ad libitum and DF groups
had high levels of Foxp3, while RORγt was high for all high fat diet groups. As there is a
relationship between Tregs and Th17 producing cells, it is interesting that the DF group
favors the Foxp3+ expressing Tregs. This is consistent with cells isolated from the intestine
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of the DF group, which had a higher number of Tregs (unpublished van der Merwe). This
suggests that the high-fiber/plant-based diet can modulate the mucosal immune system of the
intestine. The increase in the level of Verrucomicrobia (A. muciniphila) was previously
shown to be associated with the level of IL-10 and involved in improving the host
immunological homeostasis (96). Conversely, the expression RORγt was high in all mice
consuming high-fat diet. These results explain why the Foxp3+ expression was high in HFD,
where Foxp3+ inhibits RORγt-mediated IL-17A mRNA Transcription through its direct
interaction with RORγt (97). This relationship was confirmed when our data showed a low
expression in RORγt in a DF group that has a high expression level of Foxp3+. Our results
also showed the role of the HF diet in inducing intestinal inflammation and dysregulating the
gut microbiota by increasing the Firmicutes to Bacteriodetes ratio. Several studies have
similar findings as us. HFD induced the change in gut microbiota, and intestinal
inflammation through TLR4 Signaling Pathway (98, 99).
CONCLUSION
In conclusion, The current study evaluates the influence of different dietary
interventions, including a high fat, high fiber/plant-based diet, and several time-restricted
feeding protocols, that are commonly used for weight management and health improvement,
on intestinal morphology and immune parameters. The results demonstrated that the
consumption of diets high in fat (specifically saturated fat) had the biggest impact on
intestinal architecture and immune parameters. The length of the villi and depth of the crypt
were decreased in the small intestine and colon. The plant-based diet (DF) had a big effect
on the crypt regions of the small intestine and colon indicated by an increase in crypt depth
compared to high-fat diets. The number of goblet cells was also increased in villi and crypt
of the colon of the high-fiber/Daniel fast (DF) group suggesting an increase in cell
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differentiation. The HF diet has also induced the expression level of RORγt in the intestinal
tissue, while a plant-based diet had a low expression level of RORγt. Interestingly, a
plant-based diet had induced the expression level of Foxp3+.
SUGGESTIONS FOR FUTURE RESEARCH
For future research, we recommend conducting additional immunofluorescent
staining for measuring the proliferation of intestinal epithelial stem cells, goblet cells, and
evaluating the tight junction proteins. This information would provide a better understanding
of the impact of diet and fasting protocols on intestinal architectural morphology.
BUDGET
Table 4; Laboratory Equipments
Equipments

Quantity

Cost Per Unit

Total Cost

Fisherbrand, Histosette II
Tissue Cassettes

1 Box

$441.00 per box

$441.00

Absolute Ethanol, 200
Proof (100%), Fisher
Chemical

1 Bottle, 4L

$337.00 per bottle

$337.00

Histoplast Paraffin Wax,
Fisherbrand

6 Cases, 1kg
each

$142.56 per case

$855.36

Histo-Clear II

1 Gallon

$52.00 per gallon

$52.00

Hematoxylin Stain, Fisher
HealthCare

1 bottle, 500mL

$84.16 per 1 bottle

$84.16

Eosin-Y Stain, Fisher
HealthCare

1 bottle, 500mL

$54.97 per bottle

$54.97

Permount Mounting
Medium, Fisher Chemical

1 bottle, 100mL

$46.25 for 100mL
bottle

$46.25

Poly-L-Lysine Solution,
MilliporeSigma

2 bottle,
100mL/bottle

$101.00 per bottle

$202.00

SSC Buffer (Saline-Sodium
Citrate Buffer),
MilliporeSigma

2 pack, powder

$98.00 each

$98.00
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Table 4; (Continued)
Phosphate Buffered Saline
(PBS), Fisher BioReagents

1 pack, powder

$68.50

$68.50

Bovine Serum Albumin
(BSA), G-Bioscience

2 bottle,
50mL/bottle

$51.60 per bottle

$103.2

Ki-67 Mouse anti-Canine,
Human, PE-Cyanine7,
Clone: 20Raj1, eBioscience

2 each, 100 test
for 1 each

$308.00 per 1 each

$616.00

Fluoromount-G with DAPI,
eBioscience

3 bottle,
25mL/bottle

$70.00 per bottle

$210

Microscope Cover Glasses
size 22x22mm, Eisco

3 pack, 100
cover glasses per
pack

$2.50 per pack

$7.50

Positive Charged
Microscope Slide, Globe
Scientific

4 pack, 72 slides
per pack

$23.05

$92.20

All the prices are estimated based on companies' websites without adding taxes and
shipping costs. The total cost ($3268.14) is changeable, in reliance on taxes, shipping,
additional need, or price fluctuation.
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